BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/8/2017 1:51:46 AM | Browse: 1853 | Download: 2798
Publication Name World Journal of Clinical Oncology
Manuscript ID 33274
Country Canada
Received
2017-02-08 11:09
Peer-Review Started
2017-02-12 21:53
First Decision by Editorial Office Director
Return for Revision
2017-03-28 15:30
Revised
2017-04-12 11:39
Publication Fee Transferred
Editorial Processing by Scientific Editor
2017-05-11 13:48
Final Academic Decision by Editor-in-Chief
2017-05-11 23:16
Publication Technical Verification by Editorial Office Director
2017-05-31 02:46
Articles in Press
2017-05-31 02:46
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-08-03 03:48
Publish the Manuscript Online
2017-08-08 01:51
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Long-term stabilization of metastatic melanoma with sodium dichloroacetate
Manuscript Source Invited Manuscript
All Author List Akbar Khan, Doug Andrews, Jill Shainhouse and Anneke C Blackburn
Funding Agency and Grant Number
Corresponding Author Akbar Khan, MD, Medical Director, Medicor Cancer Centres Inc, 4576 Yonge St., Suite 301, Toronto, ON M2N 6N4, Canada. akhan@medicorcancer.com
Key Words Dichloroacetate; Cancer; BRAF; Melanoma; Cytostatic
Core Tip Sodium dichloroacetate (DCA) has been studied as a metabolic cancer therapy since 2007. It has been shown that DCA therapy can result in a classic response which is measured by reduction or disappearance of tumours on imaging. However, DCA can also halt cancer cell growth without causing apoptosis (cytostatic effect). This can result in long-term stabilization of metastatic cancer. We present a case of oral DCA therapy resulting in reduction and stabilization of metastatic melanoma in a 32-year-old male for over 4 years, with only minor side effects.
Publish Date 2017-08-08 01:51
Citation Khan A, Andrews D, Shainhouse J, Blackburn AC. Long-term stabilization of metastatic melanoma with sodium dichloroacetate. World J Clin Oncol 2017; 8(4): 371-377
URL http://www.wjgnet.com/2218-4333/full/v8/i4/371.htm
DOI http://dx.doi.org/10.5306/wjco.v8.i4.371
Full Article (PDF) WJCO-8-371.pdf
Full Article (Word) WJCO-8-371.doc